Literature DB >> 350045

Histoplasmosis in immunosuppressed patients.

C A Kauffman, K S Israel, J W Smith, A C White, J Schwarz, G F Brooks.   

Abstract

Infection with Histoplasma capsulatum in 58 patients whose immune responses were suppressed (Immunosuppressed patients) (16 from the present series and 42 described previously) was analyzed. The most common underlying diseases were Hodgkin's disease (29 per cent), chronic lymphocytic leukemia (19 per cent) and acute lymphocytic leukemia (17 per cent). Sixty-three per cent of the patients had received cytotoxic drugs, and 57 per cent had taken corticosteroids. Widely disseminated infection occurred in 88 per cent of the patients, with predominant involvement of lungs and organs of the reticuloendothelial system. Localized pulmonary infection was present in the remaining patients. The most useful diagnostic method was bone marrow biopsy with microscopic examination for the intracellular yeast form of H. capsulatum. Biopsy of oral lesions, lung, liver and lymph node also proved diagnostically helpful. Growth of H. capsulatum in culture was frequently too slow to be beneficial in diagnosing histoplasmosis in ill patients. Serologic methods were of little diagnostic help in this population of immunosuppressed patients. The response to amphotericin B therapy was excellent (6.7 per cent mortality rate) in those patients in whom the diagnosis was established early and in whom a full course of antifungal therapy could be given. In contrast, the mortality rate in patients who received no antifungal therapy or less than 1 g of amphotericin B was 100 per cent.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350045     DOI: 10.1016/0002-9343(78)90445-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  34 in total

Review 1.  Histoplasmosis: a clinical and laboratory update.

Authors:  Carol A Kauffman
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 2.  Immunosuppression related to collagen-vascular disease or its treatment.

Authors:  Carol Dukes Hamilton
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Identification of constituents of human neutrophil azurophil granules that mediate fungistasis against Histoplasma capsulatum.

Authors:  S L Newman; L Gootee; J E Gabay; M E Selsted
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 4.  Differential diagnoses of bone marrow granuloma.

Authors:  A Eid; W Carion; J S Nystrom
Journal:  West J Med       Date:  1996-06

5.  History of medical mycology in the united states.

Authors:  A Espinel-Ingroff
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

6.  Cutaneous and bone marrow histoplasmosis after 18 years of renal allograft transplant.

Authors:  K Y Ibrahim; N B Carvalho; E V Mimicos; H Yeh-Li; M N Sotto; F O S França
Journal:  Mycopathologia       Date:  2014-08-06       Impact factor: 2.574

7.  Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis.

Authors:  F J Gomez; J A Cain; R Gibbons; R Allendoerfer; G S Deepe
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  Immunoregulatory responses in experimental disseminated histoplasmosis: lymphoid organ histopathology and serological studies.

Authors:  R P Artz; W E Bullock
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

Review 9.  Progressive disseminated histoplasmosis in systemic lupus erythematosus-an unusual presentation of acute tenosynovitis and a literature review.

Authors:  Sian Yik Lim; Kunut Kijsirichareanchai; Richard Winn
Journal:  Clin Rheumatol       Date:  2012-10-14       Impact factor: 2.980

Review 10.  Histoplasma capsulatum recovery from the urine and a short review of genitourinary histoplasmosis.

Authors:  Alessandro C Pasqualotto; Flavio M Oliveira; Luiz Carlos Severo
Journal:  Mycopathologia       Date:  2009-01-30       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.